Search Results - "RANIN, J"

Isoniazid-resistant Mycobacterium kansasii in an HIV-positive patient, and possible development of immune reconstitution inflammatory syndrome after initiation of highly active antiretroviral therapy: case report by Despotovic, A, Savic, B, Salemovic, D, Ranin, J, Jevtovic, Dj

“…Highlights • We present the first report of Mycobacterium kansasii pulmonary infection in Serbia. • The course of illness, along with treatment, is documented…”
Get full text

Comparison of Demographic, Epidemiological, Immunological, and Clinical Characteristics of Patients with HIV Mono-infection Versus Patients Co-infected with HCV or/and HBV: A Serbian Cohort Study by Ranin, J, Salemovic, D, Brmbolic, B, Marinkovic, J, Boricic, I, Pesic, Pavlovic I, Zerjav, S, Stanojevic, M, Jevtovic, D

“…The study aimed to correlate the status of hepatitis C (HCV) and hepatitis B virus (HBV) co-infection in patients with human immunodeficiency virus (HIV)…”
Get more information

The prevalence and risk of immune restoration disease in HIV‐infected patients treated with highly active antiretroviral therapy by Jevtović, DJ, Salemović, D, Ranin, J, Pešić, I, Žerjav, S, Djurković‐Djaković, O

“…Background It is becoming increasingly clear that, during successful highly active antiretroviral therapy (HAART), a proportion of treated patients develop…”
Get full text

The metabolic syndrome, an epidemic among HIV-infected patients on HAART by Jevtović, Dj, Dragović, G, Salemović, D, Ranin, J, Djurković-Djaković, O

“…Summary Background HAART has dramatically changed the prognosis of AIDS, but has led to long-term toxicities of antiretroviral drugs. A major chronic…”
Get full text

The incidence of and risk factors for HIV-associated cognitive–motor complex among patients on HAART by Jevtović, Dj, Vanovac, V, Veselinović, M, Salemović, D, Ranin, J, Stefanova, E

“…Abstract Background While highly active antiretroviral therapy (HAART) allows for the considerable decline in the incidence of HIV-related opportunistic…”
Get full text

The dissociation between virological and immunological responses to HAART by Jevtović, D., Salemović, D., Ranin, J., Pešić, I., Žerjav, S., Djurković-Djaković, O.

“…While HAART allows for the reconstitution of immune functions in most treated HIV patients, discrepant responses including failure to achieve a significant…”
Get full text

The prognosis of patients with dissociated virological and immunological responses to HAART by Jevtović, D, Salemović, D, Ranin, J, Pešić-Pavlović, I, Korać, M, Djurković-Djaković, O

“…Abstract Background While HAART allows for the reconstitution of immune functions in most treated HIV patients, failure to achieve a significant increase in…”
Get full text

The prognosis of highly active antiretroviral therapy (HAART) treated HIV infected patients in Serbia, related to the time of treatment initiation by Jevtović, Dj, Salemović, D, Ranin, J, Dulović, O, Ilić, D, Brmbolić, B

“…Abstract Background With the introduction of highly active antiretroviral treatment (HAART) an impressive improvement in patient survival and quality of life…”
Get full text

Tracing the origin and dynamics of the HIV-1 epidemic in Serbia by Siljic, Marina, Salemovic, Dubravka, Jevtovic, Dj, Pesic-Pavlovic, Ivana, Zerjav, Sonja, Nikolic, Valentina, Ranin, J., Stanojevic, Maja

“…Since the first report of HIV infection in Serbia in 1985, the HIV-1 epidemic was very dynamic, changing the pattern in subtype distribution and prevailing…”
Get full text

The prognosis of CMV retinitis among patients with AIDS in Serbia by Dujić, M, Jevtović, Dj, Salemović, D, Ranin, J, Brmbolić, B, Djurković-Djaković, O

“…Abstract Background Cytomegalovirus (CMV) end-organ diseases, including CMV retinitis, are major opportunistic events in terminal AIDS patients. Methods A…”
Get full text

Primary HIV-1 resistance: Persistence of transmitted drug resistance mutations by Nikolic, Valentina, Salemovic, D., Jevtovic, Dj, Pesic-Pavlovic, I., Zerjav, S., Ranin, J., Siljic, M., Stanojevic, M.

“…Transmitted drug resistance (TDR) is one of the consequences of the high variability of HIV-1. The widespread use of antiretroviral therapy for the treatment…”
Get full text

The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART by Jevtović, Dj, Ranin, J, Salemović, D, Pešić, I, Dragović, G, Žerjav, S, Djurković-Djaković, O

“…Abstract Despite substantial benefits of HAART treatment of HIV-infected patients, cumulative long-term toxicity, including drug-induced hepatotoxicity, has…”
Get full text

Reduced quantity and hydrogen-peroxide production of vaginal lactobacilli in HIV positive women by Knežević, A., Stepanović, S., Ćupić, M., Jevtović, D., Ranin, J., Jovanović, T.

“…It has been suggested that vaginal lactobacilli may influence heterosexual transmission of HIV infection. The aim of this study was to compare the vaginal…”
Get full text

Long‐term survival of HIV‐infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro by Jevtović, DO, Salemović, D, Ranin, J, Pešić, I, Žerjav, S, Djurković‐Djaković, O

“…Background Highly active antiretroviral therapy (HAART) has dramatically changed the prognosis of HIV disease, even in terminally ill patients. Although these…”
Get full text

The prognosis of patients with dissociated virological and immunological responses to HAART by Jevtovic, DJ, Salemovic, DR, Ranin, JT

“…7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK…”
Get full text

Hepatitis delta infection among persons living with HIV in Europe by Béguelin, Charles, Boyd, Anders, Falconer, Karolin, Suter‐Riniker, Franziska, Rockstroh, Jürgen K., Mocroft, Amanda, Rauch, Andri, Peters, Lars, Aebi‐Popp, K., Anagnostopoulos, A., Battegay, M., Braun, D. L., Bucher, H. C., Dollenmaier, G., Egger, M., Elzi, L., Hasse, B., Hirsch, H. H., Hoffmann, M., Hösli, I., Keiser, O, Martinetti, G., Metzner, K. J., Pantaleo, G., Perreau, M., Schmid, P., Stöckle, M., Wandeler, G., Kundro, M., Schmied, B., Paduto, D., Clumeck, N., Florence, E, Sedlacek, D., Kronborg, G., Pedersen, C., Ostergaard, L., Nielsen, L. N., Aho, I., Lacombe, K., Degen, O., Hoffmann, C., Stellbrink, H. J., Chkhartishvili, N., Sambatakou, H., Adamis, G., Paissios, N., Gottfredsson, M., Tau, L., Elbirt, D., D’Arminio Monforte, A., Guaraldi, G., Mazeu, I., Mussini, C., Gabbuti, A., Lazzarin, A., Castagna, A., Gianotti, N., Bruun, J., Knysz, B., Bakowska, E., Maciejewska, K., Aksak‐Was, B., Beniowski, M., Kamerys, J., Mansinho, K., Maltez, F., Gusev, D., Khromova, I., Vdoushkina, E., Ranin, J., Laguno, M., Mallolas, J., Rojas, J., Jou, A., Santos, J. R., Sönnerborg, A., Kusejko, K., Cavassini, M., Schmid, P., Kuznetsova, A., Johnson, M. A., Winston, A., Clarke, A., Karpov, I., Losso, M., Lundgren, J., Pradier, C., Chkhartishvili, N., Miró, J. M., Paredes, R., Peters, L., Jaschinski, N., Fursa, O., Raben, D., Kristensen, D., Ahmed, A, Mocroft, A., Reekie, J., Tusch, E. S.

“…Background and Aims A high prevalence of hepatitis delta virus (HDV) infection, the most severe form of viral hepatitis, has been reported among persons living…”
Get full text

HCV reinfection after HCV therapy among HIV/HCV‐coinfected individuals in Europe by Sandri, Anastasia Karachalia, Rodger, Alison, Benfield, Thomas, Milinkovic, Ana, Stellbrink, Hans‐Jürgen, Sambatakou, Helen, Caldeira, Luis, Laguno, Monserrat, Gisinger, Martin, Rockstroh, Jürgen Kurt, Mocroft, Amanda, Losso, M, Kundro, M, Schmied, B, Vassilenko, A, Mitsura, VM, Wit, S De, Vandekerckhove, L, Begovac, J, Jilich, D, Sedlacek, D, Kronborg, G, Benfield, T, Katzenstein, T, Pedersen, C, Moller, NF, Nielsen, L N, Zilmer, K, Viard, J‐P, Girard, P‐M, Fontas, E, Behrens, G, Fätkenheuer, G., Sambatakou, H, Szlávik, J, Gottfredsson, M, Devitt, E, Hassoun, G, Elinav, H, Haouzi, M, Esposito, R, Mussini, C, Mazzotta, F, Ridolfo, A, Staub, T, Hemmer, R, Dragas, S, Reiss, P, Reikvam, DH, Gasiorowski, J, Inglot, M, Mozer‐Lisewska, I, Rozplochowski, B, Mansinho, K, Oprea, C, Davila, Carol, Yakovlev, A, Blokhina, I.N., Novogrod, Nizhny, Borodulina, E, Ranin, J, Tomazic, J, Miró, JM, Martinez, E, Martinez‐Rebollar, M, Mallolas, J, Clotet, B, Jou, A, Llibre, JM, Gutierrez, M, Mateo, G, Falconer, K, Flamholc, L, Cavassini, M, Battegay, M, Schmid, P, Milinkovic, A, Johnson, AM, Simons, E, Edwards, S, Mocroft, A, Leen, C, Karpov, I, Aho, I, Svedhem, V, Pradier, C, Chkhartishvili, N, Kowalska, JD, Wandeler, G, Paredes, R, Kirk, O, Peters, L, Bojesen, A, Raben, D, Hansen, EV, Larsen, JF, Cozzi‐Lepri, A, Pelchen‐Matthews, A, Roen, A, Reekie, J

“…Objectives Although direct‐acting antivirals (DAAs) can clear HCV in nearly all HIV/HCV‐coinfected individuals, high rates of reinfection may hamper efforts to…”
Get full text

The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study by Mocroft, Amanda, Miro, Jose M., Wandeler, Gilles, Boyd, Anders, Bremen, Kathrin, Beniowski, Marek, Mikhalik, Julia, Duvivier, Claudine, Knysz, Brygida, Bakowska, Elzbieta, Viard, Jean‐Paul, Milinkovic, Ana, Benfield, Thomas, Harxhi, A., Losso, M., Kundro, M., Schmied, B., Karpov, I., Vassilenko, A., Mitsura, V. M., Florence, E., Sedlacek, D., Gerstoft, J., Katzenstein, T., Johansen, I. S., Wiese, L., Zilmer, K., Aho, I., Lacombe, K., Fontas, E., Rockstroh, J., Behrens, G., Stellbrink, H. J., Sambatakou, H., Gottfredsson, M., Devitt, E., Turner, D., Burke, M., Shahar, E., Haouzi, M., Esposito, R., Castagna, A., Gianotti, N., Staub, T., Hemmer, R., vd Valk, M., Maeland, A., Inglot, M., Grzeszczuk, A., Parczewski, M., Maciejewska, K., Mularska, E., Jablonowska, E., Kamerys, J., Mozer‐Lisewska, I., Rozplochowski, B., Oprea, C., Gusev, D., Trofimova, T., Borodulina, E., Ranin, J., Miró, J. M., Laguno, M., Garcia, F., Martinez‐Rebollar, M., Mallolas, J., Jou, A., Paredes, R., Mateo, G., Sambeat, M. A., Svedhem, V., Flamholc, L., Kusejko, K., Braun, D., Calmy, A., Battegay, M., Simons, E., Edwards, S., Clarke, A., Losso, M., Lundgren, J., Rockstroh, J., Aho, I., Svedhem, V., Chkhartishvili, N., Matulionyte, R., Kowalska, J. D., Begovac, J., Miró, J. M., Paredes, R., Paredes, R., Larsen, J. F., Neesgaard, B., Fursa, O., Hansen, E. V., Fischer, A. H., Jensen, S. K., Pelchen‐Matthews, A., Tusch, E. S., Bannister, W.

“…Objectives The aim of this study was to assess the impact of hepatitis B virus (HBV) infection on non‐liver malignancies in people living with HIV (PLWH)…”
Get full text

Observational cohort study of rilpivirine (RPV) utilization in Europe by Cozzi-Lepri, Alessandro, Peters, Lars, Pelchen-Matthews, Annegret, Neesgaard, Bastian, De Wit, Stephane, Johansen, Isik Somuncu, Edwards, Simon, Stephan, Christoph, Adamis, Georgios, Staub, Therese, Zagalo, Alexandra, Domingo, Pere, Elbirt, Daniel, Kusejko, Katharina, Brännström, Johanna, Paduta, Dzmitry, Trofimova, Tatyana, Szlavik, Janos, Zilmer, Kai, Losso, Marcello, Van Eygen, Veerle, Pai, Helen, Lundgren, Jens, Mocroft, Amanda

“…Data on safety and effectiveness of RPV from the real-world setting as well as comparisons with other NNRTIs such as efavirenz (EFV) remain scarce…”
Get full text

Comparison of nucleoside reverse transcriptase inhibitor use as part of first-line therapy in a Serbian and a UK HIV clinic by Dragovic, G J, Smith, C J, Jevtovic, D J, Johnson, M A, Ranin, J, Salemovic, D, Youle, M S

“…Use of dideoxynucleoside reverse transcriptase inhibitors (dNRTIs) may lead to increased mitochondrial toxicity. We compared nucleoside reverse transcriptase…”
Get more information